Tanikawa T, Wilke CM, Kryczek I, Chen GY, Kao J, Nez G, Zou W
Targeting HER2-positive breast cancer: advances and future directions
Originally approved to treat diabetes, these GLP-1 agonists have since made headlines not just for their ability to manage obesity but to also positively influence a host of other conditions, from cardiovascular risk and fatty liver disease to neurogenerative diseases
In individuals with primary coenzyme Q 10 deficiency, early treatment with high-dose coenzyme Q 10 supplementation (1030 mg/kg/day in children and 1.23.0 g/day in adults) may improve the pathological phenotype, yet the effectiveness depends on the type of mutations affecting the coenzyme Q 10 biosynthetic pathway (1, 26)
Online peptide therapy platforms are expanding access but also raise quality and oversight questions that users should evaluate carefully
10.1089/ars.2014.5994 88